目前和新兴的针对脊柱肌肉缩的向疗法
Yuliya Lakhina1, Nicholas M Boulis1, Anthony Donsante1
1Department of Neurosurgery, Emory University, Atlanta, USA.
Expert review of neurotherapeutics
|October 16, 2023
概括
脊椎肌肉缩 (SMA) 治疗正在发展,经批准的疗法改善了患者的治疗结果. 未来的方向包括结合治疗和基因编辑,以提高治疗这种神经退行性疾病的有效性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊髓肌肉缩 (SMA) 是一种进展性神经退行性疾病,由SMN1基因突变导致的生存运动神经元 (SMN) 蛋白质不足引起.
- SMA的严重程度受类似SMN2基因的拷贝数的影响.
研究的目的:
- 审查目前和新兴的脊柱肌肉缩 (SMA) 的治疗策略.
- 讨论新型治疗对 SMA 治疗模式的影响.
- 探索SMA治疗发展的未来方向.
主要方法:
- 对有关SMA治疗的现有文献的综述.
- 分析最近的临床试验,涉及反感性寡核酸,病毒基因疗法和拼接调节器.
- 讨论突变纠正的潜在途径,以达到治疗性SMN蛋白水平.
主要成果:
- 目前的治疗方法,包括已批准的药物,如Spinraza,Zolgensma和Evrysdi,正在临床试验中进行研究.
- 这些疗法在症状和前症状患者中都显示出长期益处.
- 一些现有的干预措施需要重复的药物管理.
结论:
- 多种治疗选择的可用性已经将SMA治疗范式从息治疗转变为运动功能,生存和生活质量的显著改善.
- 预计未来的SMA治疗开发将涉及结合现有疗法,解决耐药性疾病方面的问题,并利用基因编辑技术.
更多相关视频
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.7K
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
13.5K
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Skeletal Muscle Relaxants: Therapeutic Uses
493
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
493
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
685
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
685
